Peter Behner - Oct 13, 2021 Form 3 Insider Report for MiNK Therapeutics, Inc. (INKT)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	INKT	Stock Option (Right to Buy)							Oct 13, 2021	Common Stock	41.7K	$3.03	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents an option to purchase shares of the common stock, which vests in three equal annual installments beginning on April 1, 2022.

Exhibit List: Exhibit 24 - Power of Attorney